文献速递创伤与烧伤重症综合管理与镇静镇痛

适用于急性院内创伤患者的衰弱评估工具的可行性与可靠性:一项系统评价

The feasibility and reliability of frailty assessment tools applicable in acute in-hospital trauma patients: A systematic review.
PubMed 文献 · J Trauma Acute Care Surg · 2022-01-01
一句话结论多数衰弱评估工具在急性创伤患者中可行性高(中位数97%),但仅临床衰弱量表(CFS)有信度数据,评分者间信度从差到好不等(Krippendorff α 0.27–0.41)。

该系统评价检索至2020年2月的相关数据库,纳入19项研究、12种衰弱评估工具,评估其在急性院内创伤患者中的可行性与可靠性。可行性以可评估患者百分比表示,中位数97%(范围49–100%),其他可行性方面(完成时间、工具可及性与成本、使用说明、培训需求)很少报告。仅3项研究评估可靠性,均为临床衰弱量表(CFS),评分者间一致率42%至>90%,Krippendorff α为0.27至0.41。作者认为多数工具可行性普遍较高,但可靠性仅对CFS有评估且结果从差到好不等,需进一步严格评估。

要点

  • 19项研究评估12种衰弱评估工具,最常评估的是临床衰弱量表(CFS)(n=5)。
  • 所有研究以可评估患者百分比报告可行性,中位数97%(范围49–100%)。
  • 完成时间、工具可及性与成本、使用说明、培训需求等其他可行性方面很少报告。
  • 仅3项研究评估可靠性,均为CFS,评分者间一致率42%至>90%,Krippendorff α 0.27至0.41。
  • 作者认为急性创伤患者衰弱评估工具的可靠性需进一步严格评估,以判断结果是否可信并可用于临床实践。

适用人群与场景

  • 急性院内创伤患者。

研究设计与关键结果

  • 系统评价,检索至2020年2月,纳入19项研究、12种衰弱评估工具,偏倚风险为一般至良好。
  • 最常评估的工具为临床衰弱量表(CFS)(n=5)。
  • 所有研究以可评估患者百分比报告可行性,中位数97%(范围49–100%)。
  • 完成时间、工具可及性与成本、使用说明、培训需求等其他可行性方面很少报告。
  • 可靠性仅3项研究评估,均为CFS;评分者间一致率42%至>90%,Krippendorff α 0.27至0.41。

证据类型、等级与局限

  • 证据类型:系统评价,证据等级 Level II。
  • 局限:其他可行性方面很少报告;可靠性仅对CFS评估且结果从差到好不等;作者认为需进一步严格评估以判断评估结果是否可信并可用于临床实践。

对床旁实践的改变

  • 作者认为多数工具可行性普遍较高,但可靠性仅对CFS有评估且结果从差到好不等,急性创伤患者衰弱评估工具的可靠性需进一步严格评估。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Assessing frailty in patients with an acute trauma can be challenging. To provide trustworthy results, tools should be feasible and reliable. This systematic review evaluated existing evidence on the feasibility and reliability of frailty assessment tools applied in acute in-hospital trauma patients.

METHODS: A systematic search was conducted in relevant databases until February 2020. Studies evaluating the feasibility and/or reliability of a multidimensional frailty assessment tool used to identify frail trauma patients were identified. The feasibility and reliability results and the risk of bias of included studies were assessed. This study was conducted and reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement and registered in Prospective Register of Systematic Reviews (ID: CRD42020175003).

RESULTS: Nineteen studies evaluating 12 frailty assessment tools were included. The risk of bias of the included studies was fair to good. The most frequently evaluated tool was the Clinical Frailty Scale (CFS) (n = 5). All studies evaluated feasibility in terms of the percentage of patients for whom frailty could be assessed; feasibility was high (median, 97%; range, 49-100%). Other feasibility aspects, including time needed for completion, tool availability and costs, availability of instructions, and necessity of training for users, were hardly reported. Reliability was only assessed in three studies, all evaluating the CFS. The interrater reliability varied between 42% and >90% agreement, with a Krippendorff α of 0.27 to 0.41.

CONCLUSION: Feasibility of most instruments was generally high. Other aspects were hardly reported. Reliability was only evaluated for the CFS with results varying from poor to good. The reliability of frailty assessment tools for acute trauma patients needs further critical evaluation to conclude whether assessment leads to trustworthy results that are useful in clinical practice.

LEVEL OF EVIDENCE: Systematic review, Level II.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Cords CI, Spronk I, Mattace-Raso FUS, et al. The feasibility and reliability of frailty assessment tools applicable in acute in-hospital trauma patients: A systematic review. J Trauma Acute Care Surg. 2022. PMID: 34789703. doi:10.1097/TA.0000000000003472

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。